We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.08B
AUM Growth
+$407M
Cap. Flow
+$226M
Cap. Flow %
4.45%
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$69.6M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$63M
3
MDB icon
MongoDB
MDB
+$59.3M
4
DV icon
DoubleVerify
DV
+$47.6M
5
FLYW icon
Flywire
FLYW
+$39.8M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$165M
2
DUOL icon
Duolingo
DUOL
+$33.1M
3
KURA icon
Kura Oncology
KURA
+$32.8M
4
COGT icon
Cogent Biosciences
COGT
+$30.6M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$25.8M

Sector Composition

Rank Sector Weight
1 Healthcare 38.81%
2 Technology 24%
3 Industrials 15.64%
4 Consumer Discretionary 5.21%
5 Utilities 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$158M 3.1%
2,669,255
-563,445
-17% -$25.8M
MTD icon
2
Mettler-Toledo International
MTD
$27.9B
$133M 2.61%
122,563
+63
+0.1% +$78.3K
ASND icon
3
Ascendis Pharma A/S
ASND
$16.5B
$124M 2.44%
1,199,000
– –
KRTX
4
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$117M 2.3%
519,700
-99,700
-16% -$20.2M
PANW icon
5
Palo Alto Networks
PANW
$265B
$115M 2.25%
1,398,148
+62,326
+5% +$5.4M
ARGX icon
6
argenx
ARGX
$54.6B
$113M 2.22%
319,400
– –
TT icon
7
Trane Technologies
TT
$97.3B
$112M 2.2%
770,836
+46,836
+6% +$7M
ODFL icon
8
Old Dominion Freight Line
ODFL
$44.2B
$111M 2.18%
891,098
+698
+0.1% +$96.6K
TTD icon
9
Trade Desk
TTD
$8.59B
$110M 2.16%
1,833,500
+6,815
+0.4% +$388K
WCN
10
Waste Connections
WCN
$41.9B
$109M 2.14%
805,270
+1,270
+0.2% +$173K
CTAS icon
11
Cintas
CTAS
$82.7B
$108M 2.12%
1,109,684
-22,716
-2% -$2.32M
GTM
12
ZoomInfo Technologies
GTM
$978M
$106M 2.08%
2,532,698
+7,279
+0.3% +$309K
XIFR
13
XPLR Infrastructure LP
XIFR
$1.12B
$105M 2.07%
1,458,142
+161,515
+12% +$12.9M
DOCS icon
14
Doximity
DOCS
$3.82B
$103M 2.03%
3,411,287
+1,898,685
+126% +$69.6M
FIVN icon
15
FIVE9
FIVN
$2.12B
$102M 2%
1,355,000
+107,200
+9% +$10.4M
CRWD icon
16
CrowdStrike
CRWD
$189B
$100M 1.97%
2,434,688
+2,288
+0.1% +$105K
ROP icon
17
Roper Technologies
ROP
$38.5B
$96.3M 1.9%
267,872
+31,172
+13% +$12.7M
XMTR icon
18
Xometry
XMTR
$4.69B
$91.7M 1.8%
1,615,098
+210,934
+15% +$9.85M
GH icon
19
Guardant Health
GH
$20.2B
$90.5M 1.78%
1,681,000
– –
IDXX icon
20
Idexx Laboratories
IDXX
$44.1B
$83.9M 1.65%
257,538
+238
+0.1% +$87.4K
LOW icon
21
Lowe's Companies
LOW
$118B
$82.3M 1.62%
437,967
+367
+0.1% +$71.5K
DLO icon
22
dLocal
DLO
$4.41B
$80.9M 1.59%
3,943,403
+527,960
+15% +$14M
POOL icon
23
Pool Corp
POOL
$6.95B
$78.6M 1.55%
247,100
– –
BHVN icon
24
Biohaven
BHVN
$2.08B
$74.9M 1.47%
+506,827
New +$3.68M
KNBE
25
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$68M 1.34%
3,267,317
-945,166
-22% -$17.4M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Eventide Asset Management held 154 positions worth $5.08B, up 8.7% from $4.68B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $226M of net new capital in Q3 2022, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was DoubleVerify: 1,847,144 shares worth $50.5M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Cogent Biosciences, an estimated $30.6M trimmed.

  • Eventide Asset Management's largest Q3 2022 buy was DoubleVerify: 1,847,144 shares worth $50.5M.
  • Eventide Asset Management added most to Doximity in Q3 2022, an estimated $69.6M increase.
  • Eventide Asset Management's biggest Q3 2022 reduction was Cogent Biosciences, cutting an estimated $30.6M.
  • Eventide Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $5.08B portfolio in Q3 2022.
  • Eventide Asset Management opened 18 new positions and closed 16 in Q3 2022.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $5.08B.

Based on Eventide Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.